Two Sigma Advisers
HLVX

Two Sigma Advisers’s HilleVax HLVX Stock Holding History

Two Sigma Advisers’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-211,600
Closed -$421K – 2472
2025
Q2 		$421K Buy
211,600
+109,224
+107% +$200K ﹤0.01% 1826
2025
Q1 		$148K Buy
102,376
+61,176
+148% +$113K ﹤0.01% 2191
2024
Q4 		$85.3K Buy
41,200
+17,900
+77% +$33.6K ﹤0.01% 2238
2024
Q3 		$41K Buy
23,300
+7,200
+45% +$18.5K ﹤0.01% 2226
2024
Q2 		$233K Buy
+16,100
New +$221K ﹤0.01% 2163

Two Sigma Advisers's HLVX Position: Q3 2025 in Review

Two Sigma Advisers sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 211,600 shares — an estimated $421K sold.

Two Sigma Advisers first reported a position in HLVX in Q2 2024 and held it in 5 quarters. The position peaked at $421K in Q2 2025. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • Two Sigma Advisers reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 211,600 HilleVax shares in Q3 2025, an estimated $421K.
  • Two Sigma Advisers first reported a position in HilleVax in Q2 2024 and held it in 5 quarters.
  • Two Sigma Advisers's HilleVax position peaked at $421K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Two Sigma Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.